19-54852235-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_006737.4(KIR3DL2):āc.308T>Cā(p.Leu103Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000894 in 1,610,748 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_006737.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIR3DL2 | NM_006737.4 | c.308T>C | p.Leu103Pro | missense_variant | 3/9 | ENST00000326321.7 | NP_006728.2 | |
KIR3DL2 | NM_001242867.2 | c.308T>C | p.Leu103Pro | missense_variant | 3/8 | NP_001229796.1 | ||
KIR3DL2 | XM_047438795.1 | c.308T>C | p.Leu103Pro | missense_variant | 3/7 | XP_047294751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIR3DL2 | ENST00000326321.7 | c.308T>C | p.Leu103Pro | missense_variant | 3/9 | 1 | NM_006737.4 | ENSP00000325525.3 | ||
KIR3DL2 | ENST00000270442.5 | c.308T>C | p.Leu103Pro | missense_variant | 3/8 | 1 | ENSP00000270442.5 |
Frequencies
GnomAD3 genomes AF: 0.000277 AC: 42AN: 151372Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 24AN: 232606Hom.: 2 AF XY: 0.0000956 AC XY: 12AN XY: 125488
GnomAD4 exome AF: 0.0000644 AC: 94AN: 1459264Hom.: 1 Cov.: 33 AF XY: 0.0000606 AC XY: 44AN XY: 725850
GnomAD4 genome AF: 0.000330 AC: 50AN: 151484Hom.: 3 Cov.: 32 AF XY: 0.000270 AC XY: 20AN XY: 74058
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at